Sandbox:ajay: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ajay Gade (talk | contribs)
nocaptcha
1,722 edits
No edit summary
Ajay Gade (talk | contribs)
nocaptcha
1,722 edits
Line 46: Line 46:


-Immobilization
-Immobilization
{| class="wikitable"
! colspan="9" style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF||Differential diagnosis of hyperparathyroidism on the basis of hypercalcemia}}
|-
! colspan="2" rowspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Disorder}}
! rowspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Mechanism of hypercalcemia}}
! rowspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Clinical features}}
! colspan="4" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Laboratory findings}}
! rowspan="2" style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Imaging & diagnostic modalities}}
|-
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|PTH}}
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Calcium}}
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Phosphate}}
! style="background: #7d7d7d; text-align: center;" |{{fontcolor|#FFF|Other findings}}
|-
| rowspan="3" style="background: #F0FFFF; text-align: center;" |'''Hyperparathyroidism'''
| style="background: #F0FFFF; text-align: center;" |Primary hyperparathyroidism
| style="background: #DCDCDC;" |Increase in [[secretion]] of [[parathyroid hormone]] (PTH) from a primary process in [[parathyroid gland]]. Parathyroid hormone causes increase in serum calcium.
| style="background: #DCDCDC;" |
* Usually asymptomatic
* Hypercalcemia detected on routine biochemical  panel
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↓/Normal
| style="background: #DCDCDC; text-align: center;" |Normal/↑ calcitriol
| rowspan="3" style="background: #DCDCDC;" |Findings of bone resorption:
* X-ray
* DXA
Preoperative localization of hyperfunctioning parathyroid gland:
* Non-Invasive
** Tc-99m sestamibi scintigraphy
** Neck ultrasound
** 4D-CT
** SPET(P-SPECT)
** PET
** MRI
* Invasive:
** Super sensitive venous sampling
** Selective arteriography
** Angiography
Predicting post-operative success:
* Intraoperative parathyroid hormone monitoring
|-
| style="background: #F0FFFF; text-align: center;" |Secondary hyperparathyroidism
| style="background: #DCDCDC;" |Increase in [[secretion]] of [[parathyroid hormone]] (PTH) from a secondary process. Parathyroid hormone causes increase in serum calcium.
| style="background: #DCDCDC;" |
* May present with history of:
** Chronic renal failure
** Vitamin D deficiency
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↓/Normal
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
|-
| style="background: #F0FFFF; text-align: center;" |Tertiary hyperparathyroidism
| style="background: #DCDCDC;" |Continuous elevation of [[parathyroid hormone]] (PTH) even after successful treatment of the secondary cause of  elevated parathyroid hormone. Parathyroid hormone causes increase in serum calcium.
| style="background: #DCDCDC;" |
* Usually present with history of:
** Kidney transplant
* Usually hyperplasia of all four parathyroid glands
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
|-
| colspan="2" style="background: #F0FFFF; text-align: center;" |Familial hypocalciuric hypercalcemia
| style="background: #DCDCDC;" |
* This is a genetic disorder caused my mutation in calcium-sensing receptor gene.
| style="background: #DCDCDC;" |
* This is a benign condition and does not require treatment.
| style="background: #DCDCDC; text-align: center;" |Normal/↑
| style="background: #DCDCDC; text-align: center;" |Normal/↑
| style="background: #DCDCDC; text-align: center;" |
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC;" |
* Calcium/creatinine clearance ratio
|-
| rowspan="4" style="background: #F0FFFF; text-align: center;" |'''Malignancy'''<ref name="pmid26713296">{{cite journal |vauthors=Mirrakhimov AE |title=Hypercalcemia of Malignancy: An Update on Pathogenesis and Management |journal=N Am J Med Sci |volume=7 |issue=11 |pages=483–93 |year=2015 |pmid=26713296 |pmc=4683803 |doi=10.4103/1947-2714.170600 |url=}}</ref>
| style="background: #F0FFFF; text-align: center;" |Humoral hypercalcemia of malignancy<ref name="pmid1346019">{{cite journal |vauthors=Ratcliffe WA, Hutchesson AC, Bundred NJ, Ratcliffe JG |title=Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia |journal=Lancet |volume=339 |issue=8786 |pages=164–7 |year=1992 |pmid=1346019 |doi=10.1016/0140-6736(92)90220-W |url=}}</ref><ref name="pmid7962324">{{cite journal |vauthors=Ikeda K, Ohno H, Hane M, Yokoi H, Okada M, Honma T, Yamada A, Tatsumi Y, Tanaka T, Saitoh T |title=Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma |journal=J. Clin. Endocrinol. Metab. |volume=79 |issue=5 |pages=1322–7 |year=1994 |pmid=7962324 |doi=10.1210/jcem.79.5.7962324 |url=}}</ref><ref name="pmid12679445">{{cite journal |vauthors=Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF |title=Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers |journal=J. Clin. Endocrinol. Metab. |volume=88 |issue=4 |pages=1603–9 |year=2003 |pmid=12679445 |doi=10.1210/jc.2002-020773 |url=}}</ref>
| style="background: #DCDCDC;" |Tumor cells secretes parathyroid hormone related protein (PTHrP) which has similar action as parathyroid hormone.
| style="background: #DCDCDC;" |
* Most common cause of malignancy related hypercalcemia.
* Usually present in solid tumors
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↓/Normal
| style="background: #DCDCDC; text-align: center;" |↑ PTHrP
Normal/↑ calcitriol
| style="background: #DCDCDC;" |
* Chest X-ray
* CT scan
* MRI
|-
| style="background: #F0FFFF; text-align: center;" |Osteolytic tumors
| style="background: #DCDCDC;" |Multiple myeloma produces osteolysis of bones causing hypercalcemia. Osteolytic metastasis can cause bone resorption causing hypercalcemia.
| style="background: #DCDCDC;" |
* Most commonly present in multiple myeloma and breast cancer.
| style="background: #DCDCDC; text-align: center;" |↓
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC;" |
* DXA
* X-ray
* Mammography
* Ultrasound
* ESR
* Serum protein electrophoresis
|-
| style="background: #F0FFFF; text-align: center;" |Production of calcitirol
| style="background: #DCDCDC;" |Some tumors has ectopic activity of 1-alpha-hydroxylase leading to increased production of calcitriol. Calcitriol is active form of vitamin D and causes hypercalcemia.
| style="background: #DCDCDC;" |
* Most commonly present in lymphomas and in some ovarian germ cell tumors.
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑ Calcitriol
| style="background: #DCDCDC;" |
* CT scan
* MRI
|-
| style="background: #F0FFFF; text-align: center;" |Ectopic parathyroid hormone<ref name="pmid16263810">{{cite journal |vauthors=VanHouten JN, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski JJ, Udelsman R |title=Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene |journal=J. Clin. Endocrinol. Metab. |volume=91 |issue=2 |pages=580–3 |year=2006 |pmid=16263810 |doi=10.1210/jc.2005-2095 |url=}}</ref>
| style="background: #DCDCDC;" |Some tumors leads to ectopic production of parathyroid hormone.
| style="background: #DCDCDC;" |
* In rare instances, small cell carcinoma of lung may produce hypercalcemia by this process.
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↓/Normal
| style="background: #DCDCDC; text-align: center;" |Normal/↑ Calcitriol
| style="background: #DCDCDC;" |
* Chest X-ray
* CT scan
* MRI
|-
| rowspan="2" style="background: #F0FFFF; text-align: center;" |'''Medication induced'''
| style="background: #F0FFFF; text-align: center;" |Lithium<ref name="pmid2918061">{{cite journal |vauthors=Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S |title=Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume |journal=J. Clin. Endocrinol. Metab. |volume=68 |issue=3 |pages=654–60 |year=1989 |pmid=2918061 |doi=10.1210/jcem-68-3-654 |url=}}</ref>
| style="background: #DCDCDC;" |Lithium lowers urinary calcium and causes hypercalcemia. Lithium has been reported to cause an increase in parathyroid hormones and enlargement if parathyroid gland after weeks to months of therapy.
| style="background: #DCDCDC;" |
* History of mood disorder
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC;" |
* Lithium levels
|-
| style="background: #F0FFFF; text-align: center;" |Thiazide diuretics
| style="background: #DCDCDC;" |Thiazide diuretics lowers urinary calcium excretion and causes hypercalcemia
| style="background: #DCDCDC;" |
* History of cardiac disorder
* Rarely causes hypercalcemia
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC;" | --
|-
| rowspan="2" style="background: #F0FFFF; text-align: center;" |'''Nutritional'''
| style="background: #F0FFFF; text-align: center;" |Milk-alkali syndrome
| style="background: #DCDCDC;" |Hypercalcemia is be caused by high intake of calcium carbonate
| style="background: #DCDCDC;" |
* History of
** High milk intake
** Excess calcium intake for treating:
*** Osteoporosis
*** Dyspepsia
* May lead to metabolic alkalosis and renal insufficiency.
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC;" |
* Renal function test
|-
| style="background: #F0FFFF; text-align: center;" |Vitamin D toxicity
| style="background: #DCDCDC;" |Excess vitamin D causes increased absorption of calcium from intestine causing hypercalcemia.
| style="background: #DCDCDC;" |
* History of:
** Excess intake vitamin D
** Excess milk fortified with vitamin D<ref name="pmid1313547">{{cite journal |vauthors=Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW |title=Hypervitaminosis D associated with drinking milk |journal=N. Engl. J. Med. |volume=326 |issue=18 |pages=1173–7 |year=1992 |pmid=1313547 |doi=10.1056/NEJM199204303261801 |url=}}</ref>
** Topical application of vitamin D analogue analogue calcipotriol<ref name="pmid8120527">{{cite journal |vauthors=Hoeck HC, Laurberg G, Laurberg P |title=Hypercalcaemic crisis after excessive topical use of a vitamin D derivative |journal=J. Intern. Med. |volume=235 |issue=3 |pages=281–2 |year=1994 |pmid=8120527 |doi= |url=}}</ref>
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑ Vitamin D (calcidiol and/or calcitriol)
| style="background: #DCDCDC;" | --
|-
| style="background: #F0FFFF; text-align: center;" |'''Granulomatous disease'''
| style="background: #F0FFFF; text-align: center;" |Sarcoidosis<ref name="pmid9215298">{{cite journal |vauthors=Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E |title=gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses |journal=J. Clin. Endocrinol. Metab. |volume=82 |issue=7 |pages=2222–32 |year=1997 |pmid=9215298 |doi=10.1210/jcem.82.7.4074 |url=}}</ref>
| style="background: #DCDCDC;" |Hypercalcemia is causes by endogeous production of calcitriol by disease-activated macrophages.
| style="background: #DCDCDC;" |
* History of:
** Cough
** Dyspnea
** Chest pain
** Tiredness or weakness
** Fever
** Weight loss
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |↑
| style="background: #DCDCDC; text-align: center;" | --
| style="background: #DCDCDC; text-align: center;" |
* ↑ Calcitriol
* ↑ ACE levels
| style="background: #DCDCDC;" |
* Chest X-ray
* Biopsy
|}

Revision as of 15:01, 21 September 2017

Differentials

Familial hypocalciuric hypercalcemia should be differentiated from other causes of hypercalcemia. Causes of hypercalcemia include:

Parathyroid-related

Hyperparathyroidism

-Primary hyperparathyroidism

-Secondary hyperparathyroidism

-Tertiary hyperparathyroidism

Non-parathyroid related

-Malignancy

-Humoral hypercalcemia of malignancy

-Osteolytic tumors

-Production of calcitriol by tumors

-Ectopic parathyroid hormone production

Medication-induced

-Thiazide diuretics

-Lithium

Other

-Nutritional

-Milk-alkali syndrome

-Vitamin D toxicity

-Granulomatous disease

-Sarcoidosis

-Surgical

-Immobilization


Differential diagnosis of hyperparathyroidism on the basis of hypercalcemia
Disorder Mechanism of hypercalcemia Clinical features Laboratory findings Imaging & diagnostic modalities
PTH Calcium Phosphate Other findings
Hyperparathyroidism Primary hyperparathyroidism Increase in secretion of parathyroid hormone (PTH) from a primary process in parathyroid gland. Parathyroid hormone causes increase in serum calcium.
  • Usually asymptomatic
  • Hypercalcemia detected on routine biochemical panel
 ↑ ↑ ↓/Normal Normal/↑ calcitriol Findings of bone resorption:
  • X-ray
  • DXA

Preoperative localization of hyperfunctioning parathyroid gland:

  • Non-Invasive
    • Tc-99m sestamibi scintigraphy
    • Neck ultrasound
    • 4D-CT
    • SPET(P-SPECT)
    • PET
    • MRI
  • Invasive:
    • Super sensitive venous sampling
    • Selective arteriography
    • Angiography

Predicting post-operative success:

  • Intraoperative parathyroid hormone monitoring
Secondary hyperparathyroidism Increase in secretion of parathyroid hormone (PTH) from a secondary process. Parathyroid hormone causes increase in serum calcium.
  • May present with history of:
    • Chronic renal failure
    • Vitamin D deficiency
 ↑ ↓/Normal ↑ --
Tertiary hyperparathyroidism Continuous elevation of parathyroid hormone (PTH) even after successful treatment of the secondary cause of elevated parathyroid hormone. Parathyroid hormone causes increase in serum calcium.
  • Usually present with history of:
    • Kidney transplant
  • Usually hyperplasia of all four parathyroid glands
 ↑ ↑ ↑ --
Familial hypocalciuric hypercalcemia
  • This is a genetic disorder caused my mutation in calcium-sensing receptor gene.
  • This is a benign condition and does not require treatment.
 Normal/↑ Normal/↑ --
  • Calcium/creatinine clearance ratio
Malignancy[1] Humoral hypercalcemia of malignancy[2][3][4] Tumor cells secretes parathyroid hormone related protein (PTHrP) which has similar action as parathyroid hormone.
  • Most common cause of malignancy related hypercalcemia.
  • Usually present in solid tumors
 -- ↑ ↓/Normal ↑ PTHrP

Normal/↑ calcitriol

  • Chest X-ray
  • CT scan
  • MRI
Osteolytic tumors Multiple myeloma produces osteolysis of bones causing hypercalcemia. Osteolytic metastasis can cause bone resorption causing hypercalcemia.
  • Most commonly present in multiple myeloma and breast cancer.
 ↓ ↑ -- --
  • DXA
  • X-ray
  • Mammography
  • Ultrasound
  • ESR
  • Serum protein electrophoresis
Production of calcitirol Some tumors has ectopic activity of 1-alpha-hydroxylase leading to increased production of calcitriol. Calcitriol is active form of vitamin D and causes hypercalcemia.
  • Most commonly present in lymphomas and in some ovarian germ cell tumors.
 -- ↑ -- ↑ Calcitriol
  • CT scan
  • MRI
Ectopic parathyroid hormone[5] Some tumors leads to ectopic production of parathyroid hormone.
  • In rare instances, small cell carcinoma of lung may produce hypercalcemia by this process.
 ↑ ↑ ↓/Normal Normal/↑ Calcitriol
  • Chest X-ray
  • CT scan
  • MRI
Medication induced Lithium[6] Lithium lowers urinary calcium and causes hypercalcemia. Lithium has been reported to cause an increase in parathyroid hormones and enlargement if parathyroid gland after weeks to months of therapy.
  • History of mood disorder
 ↑ ↑ -- --
  • Lithium levels
Thiazide diuretics Thiazide diuretics lowers urinary calcium excretion and causes hypercalcemia
  • History of cardiac disorder
  • Rarely causes hypercalcemia
 -- ↑ -- -- --
Nutritional Milk-alkali syndrome Hypercalcemia is be caused by high intake of calcium carbonate
  • History of
    • High milk intake
    • Excess calcium intake for treating:
      • Osteoporosis
      • Dyspepsia
  • May lead to metabolic alkalosis and renal insufficiency.
 -- ↑ -- --
  • Renal function test
Vitamin D toxicity Excess vitamin D causes increased absorption of calcium from intestine causing hypercalcemia.
  • History of:
    • Excess intake vitamin D
    • Excess milk fortified with vitamin D[7]
    • Topical application of vitamin D analogue analogue calcipotriol[8]
 -- ↑ -- ↑ Vitamin D (calcidiol and/or calcitriol) --
Granulomatous disease Sarcoidosis[9] Hypercalcemia is causes by endogeous production of calcitriol by disease-activated macrophages.
  • History of:
    • Cough
    • Dyspnea
    • Chest pain
    • Tiredness or weakness
    • Fever
    • Weight loss
 -- ↑ --
  • ↑ Calcitriol
  • ↑ ACE levels
  • Chest X-ray
  • Biopsy
  1. ↑ Mirrakhimov AE (2015). "Hypercalcemia of Malignancy: An Update on Pathogenesis and Management". N Am J Med Sci. 7 (11): 483–93. doi:10.4103/1947-2714.170600. PMC 4683803. PMID 26713296.
  2. ↑ Ratcliffe WA, Hutchesson AC, Bundred NJ, Ratcliffe JG (1992). "Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia". Lancet. 339 (8786): 164–7. doi:10.1016/0140-6736(92)90220-W. PMID 1346019.
  3. ↑ Ikeda K, Ohno H, Hane M, Yokoi H, Okada M, Honma T, Yamada A, Tatsumi Y, Tanaka T, Saitoh T (1994). "Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma". J. Clin. Endocrinol. Metab. 79 (5): 1322–7. doi:10.1210/jcem.79.5.7962324. PMID 7962324.
  4. ↑ Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF (2003). "Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers". J. Clin. Endocrinol. Metab. 88 (4): 1603–9. doi:10.1210/jc.2002-020773. PMID 12679445.
  5. ↑ VanHouten JN, Yu N, Rimm D, Dotto J, Arnold A, Wysolmerski JJ, Udelsman R (2006). "Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene". J. Clin. Endocrinol. Metab. 91 (2): 580–3. doi:10.1210/jc.2005-2095. PMID 16263810.
  6. ↑ Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S (1989). "Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume". J. Clin. Endocrinol. Metab. 68 (3): 654–60. doi:10.1210/jcem-68-3-654. PMID 2918061.
  7. ↑ Jacobus CH, Holick MF, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW (1992). "Hypervitaminosis D associated with drinking milk". N. Engl. J. Med. 326 (18): 1173–7. doi:10.1056/NEJM199204303261801. PMID 1313547.
  8. ↑ Hoeck HC, Laurberg G, Laurberg P (1994). "Hypercalcaemic crisis after excessive topical use of a vitamin D derivative". J. Intern. Med. 235 (3): 281–2. PMID 8120527.
  9. ↑ Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E (1997). "gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses". J. Clin. Endocrinol. Metab. 82 (7): 2222–32. doi:10.1210/jcem.82.7.4074. PMID 9215298.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:ajay&oldid=1363425"